JFG
ARKG icon

Jefferies Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jefferies Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7M Buy
+1,300,000
New +$41.4M 0.36% 52

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's ARKG Position: Q2 2026 in Review

Jefferies Financial Group increased its ARK Genomic Revolution ETF (ARKG) stake by 140% in Q2 2026, buying an estimated $33.4M and bringing the position to 1,800,113 shares worth $75.7M. The position accounts for 0.5% of the portfolio, ranked #29.

Jefferies Financial Group first reported a position in ARKG in Q4 2022 and has held it in 6 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Jefferies Financial Group held 1,800,113 shares of ARK Genomic Revolution ETF worth $75.7M as of Q2 2026.
  • Jefferies Financial Group bought 1,049,292 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $33.4M.
  • ARK Genomic Revolution ETF made up 0.5% of Jefferies Financial Group's portfolio in Q2 2026, its #29 holding.
  • Jefferies Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 6 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.